90-day implantable port maintenance flushing
“The purpose of this evidence-based practice initiative was to determine whether locking TIVADs with normal saline alone during a 90-day maintenance flushing protocol resulted in an increase in partial occlusions” Ramsey et al (2026).
Implantable port placement in an outpatient vascular access center – Full Text
“To our knowledge, port implantation in nonhospital settings has not been reported in peer-reviewed literature. Here, we report our experience with port placement in freestanding outpatient vascular centers” Gray et al (2026).
Stuck pediatric implantable port removal
“Long-term central venous catheters removal is often complicated by peri catheter adhesions and calcification. Owing to the risk of significant complications, removal should be performed only when clinically indicated and preferably in specialized centers with access to interventional radiology and cardiac surgery” Bawazir et al (2026).
Treating fibrin sheath-induced implantable port dysfunction – Full Text
“Direct oral anticoagulant administration can be a potentially effective and safe strategy for managing fibrin sheath-induced central venous port system dysfunction formation” Nagata et al (2026).
Severe complication of implantable port chamber – Full Text
“Long-term implantable ports may cause severe complications even years after placement. This case highlights the importance of verifying catheter integrity and tip position before reusing a dormant central venous access device” Grolleau et al (2026).
Difficult port catheter removal – Full Text
“The ipsilateral pull-through technique is a useful method to detach adhered catheters during difficult TIVAD removal” Matsuo et al (2026).
Complications of port-a-cath systems – Full Text
“PCSs are generally safe in oncology patients; infections and thrombosis predominate as PCS-related complications, but rarely require removal, and standardized care enables long-term use, improving patient quality of life” Nemeș et al (2026).
Correlation of implantable port size with complications – Full Text
“Port reservoir thickness is an independent predictor of skin erosion requiring revision. Thicker ports were linked to higher complication rates, particularly in patients receiving anti-VEGF therapy, underscoring the importance of device selection and design considerations in clinical practice” Yavuz and Iscan (2025).
Topical anesthetics for non-coring needle insertion – Full Text
“Application of EMLA cream for 64 minutes or tetracaine gel for 44 minutes at the site of TIVADs resulted in a safely conducted, painless non-coring needle puncture for 95% of patients” Jiang et al (2025).
Comparison of two puncture methods for implantable port insertion – Full Text
“We present a method that makes the incision before vein puncture for guidewire and dilator insertion in TIVAD placement. This method may result in less bleeding and improved appearance for patients undergoing chemotherapy for cancer” Fang et al (2025).
Bacterial transfer associated with implantable port needle design – Full Text
“The Forsvall Port needle significantly reduces bacterial transfer into TIVAPs, which could potentially decrease TIVAP-related infections. This study demonstrates a strong association between needle design and bacterial transfer during TIVAP access” Pärsson et al (2025).
Image-guided chemoport insertion by a vascular surgeon
“Standardized, image-guided chemoport insertion by a vascular surgeon results in a low complication rate. The catheter length measurements may serve as a useful reference, particularly in settings lacking fluoroscopic guidance” Kim (2025).
Vein access options for totally implantable venous access ports – Full Text
“For breast cancer patients, the ultrasound-guided AxV approach for TIVAP provides superior early postoperative comfort, long-term cosmetic results, and patient satisfaction without increasing early complication risks, representing a significant patient-centered advancement in venous access” He et al (2025).
GAVeCeLT bundle for chest-port insertion – Full Text
“This paper describes an insertion bundle-developed by GAVeCeLT, the Italian Group of Long-Term Venous Access Devices, and nicknamed “SIC-Port” (Safe Insertion of Chest-Port)-which consists of few evidence-based strategies aiming to further minimize all immediate, early, or late complications potentially associated with chest-port insertion” Brescia et al (2025).
Implantable port management in the oncology ward
“This project aimed to improve nurses’ IVP management in oncology patients by implementing evidence-based recommendations” Wang et al (2025).
Chemoport-associated endocarditis – Full Text
“This case highlights the importance of heightened clinical suspicion and a multidisciplinary approach to achieve successful outcomes in rare presentations of endocarditis” Ralston et al (2025).
Case study highlights complex port removal – Full Text
“This case series revisits endoluminal balloon dilatation, an emerging technique for removing hemodialysis catheters, to demonstrate its application and efficacy in retrieving long-term port-a-cath catheters complicated by fibrotic encapsulation, calcification, and stenosis” Thomas et al (2025).
Implantable port pocket skin necrosis – Full Text
“Proactive preparation of the local pocket skin may help mitigate the risk of pocket skin necrosis. In cases where necrosis occurs, creating an adjacent new pocket for hub relocation constitutes an effective approach for management and preservation of treatment continuity” Li et al (2025).
SVC recanalization during implantable port placement – Full Text
“A patient with a history of cystic fibrosis and bilateral lung transplant presented internal jugular port placement for extracorporeal photopheresis in the setting of acute rejection. Imaging demonstrated chronic calcific stenosis of the right brachiocephalic vein and superior vena cava (SVC)” DePalma et al (2025).
Complications of chest port implantation
“Complications are grouped into incision-, catheter-, and reservoir-related categories. Incision complications include adhesive dermatitis, suture pseudoinfection, wound dehiscence, and erosion. Catheter issues include arrhythmias, central venous stenosis, fracture, fibrin sheath formation, thrombosis, and migration, each with distinct clinical implications. Reservoir complications such as port flipping and extravasation may interrupt therapy and cause tissue injury” Schutt et al (2025).
When to remove implantable vascular access ports – Full Text
“In patients with breast cancer who do not require regular intravenous administration, it may be recommended to consider removing the infusion port after 2 years to reduce the risks of secondary catheterization and reduce medical costs, unless irreversible adverse events affect the correct use of the PORT” Luo et al (2025).
[177Lu]Lu-PSMA-617-administration using totally implantable venous access port
“These findings suggest that [177Lu]Lu-PSMA-617 administration via TIVAP appears safe and effective, supporting its use in clinical practice particularly for patients with limited peripheral venous access” Lombard et al (2025).
Breast cancer patients with implantable ports experience of chemotherapy – Full Text
“To analyze the occurrence of anxiety and its influencing factors in stable stage breast cancer patients after chemotherapy with Implanted Venous Access Port (IVAP)” Wen et al (2025).
Outcomes associated with implantable ports in gastrointestinal cancer chemotherapy – Full text
“In patients with gastrointestinal cancer undergoing chemotherapy, TIVAPs are associated with a lower incidence of catheter-related complications and improved QoL than PICCs” Ye et al (2025).
Guidewire entrapment during implantable port placement – Full Text
“This study reports a case of a J-shaped guidewire entrapped in a Chiari network during central venous port insertion” Kuhara et al (2025).
How to identify cavoatrial junction position of totally implantable venous-access port – Full Text
“The chest radiograph method could more effectively predict the CAJ position than the surface measurement in the overall cohort. However, subgroup analysis revealed that this advantage was not statistically significant in patients with BMI > 24.9 kg/m2, suggesting reduced efficacy in high-BMI populations” Li et al (2025).
Venous Port implantation in persistent left superior vena cava – Full Text
“The rare persistent left superior vena cava with variant azygos vein should not be a contraindication for venous port implantation after a comprehensive evaluation” Zhang and Wu (2025).
Repositioning of malpositioned central venous port catheter – Full Text
“This report describes the use of an artificial snare technique for the repositioning of a central venous port catheter that was identified as malpositioned six months following its insertion” Kuzan and Anbar (2025).
Review of subcutaneous implantable port catheter insertion through subclavian vein – Full Text
“The aim of this study was to present our clinical experience in patients undergoing subcutaneous venous port catheter (SVPC) placement through subclavian vein for chemotherapy” Derdiyok and Temel (2025).
Treating local skin infections around totally implantable venous access ports – Full Text
“To conduct a comparative assessment of the safety and efficacy of the port repositioning technique and the port re-implantation technique in treating periport skin infections associated with totally implantable venous access ports (TIVAPs)” Sun et al (2025).